Article Details

Sentiment for Akebia Therapeutics (NASDAQ:AKBA)

Retrieved on: 2019-12-06 01:37:30

Tags for this article:

Click the tags to see associated articles and topics

Sentiment for Akebia Therapeutics (NASDAQ:AKBA). View article details on hiswai:

Excerpt

<div><b>Baupost Group</b> Llc Ma owns 24.47 million shares or 1.09% of their US portfolio. Moreover, Nantahala Capital Management Llc has 0.84% invested in ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up